Machine signal
Active cluster sell — 5 distinct insiders, $2.6M, window ends Jul 16, 2026.
Figures computed from official regulatory filings — .
Analysttarget 28 USD (+173%) · consensus 4.78/5 · 9 buy · 0 hold · 0 sell
Ownershipinsiders 0.56% · institutions 116.1% · short 22.9% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Monte Rosa Therapeutics, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Monte Rosa Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. The company develops orally bioavailable molecular glue degraders (MGDs), such as MRT-2359 for the treatment of MYC-driven tumors; MRT-6160 for the treatment of neurologic and systemic autoimmune and inflammatory diseases; and MRT-8102 for the treatment of inflammatory diseases driven by IL-1a, IL-1ß and IL-18, as well as damage-associated molecular patterns. In addition, it develops CDK2 to treat multiple cancers, including ovarian, endometrial, gastric and breast. Further, its pipeline includes programs in immunology and inflammation indications, oncology, cardiovascular, metabolic, and genetic diseases. The company also develops QuEEN, a discovery engine, to enable its target-centric MGD discovery and development approach and its rational design of MGD product candidates. It has a strategic collaboration and licensing agreement with F. Hoffmann-La Roche Ltd.; and Novartis. The company was incorporated in 2019 and is headquartered in Boston, Massachusetts.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
17 buys46 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Warmuth Markus | Sell | $220.2K | Unusual size | SEC |
| Champoux Jennifer | Exercise | $17.3K | Unusual size | SEC |
| Champoux Jennifer | Sell | $101.7K | Unusual size | SEC |
| Champoux Jennifer | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Townson Sharon | Sell | $9.7K | SEC |
| Townson Sharon | Exercise | $36.8K | SEC |
| Townson Sharon | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Townson Sharon | Sell | $130.2K | SEC |
| Behbahani Alitrack record | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Behbahani Alitrack record | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Behbahani Alitrack record | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Janku Filip | Sell | $132.5K | SEC |
| Janku Filip | Exercise | $72.5K | SEC |
| Janku Filip | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Manning Anthony M. | Exercise | $41.6K | SEC |
| Manning Anthony M. | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Janku Filip | Sell | $137.7K | SEC |
| Janku Filip | Exercise | $45.4K | SEC |
| Manning Anthony M. | Sell | $231.1K | SEC |
| Janku Filip | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Janku Filip | Exercise | $45.4K | SEC |
| Champoux Jennifer | Exercise | $8.7K | SEC |
| Champoux Jennifer | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Townson Sharon | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Janku Filip | ExerciseD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |